Waldenström's macroglobulinemia (WM) is an indolent but incurable B-cell malignancy. Over the last decade, advances in the molecular field brought about by the use of high-throughput genomic analyses - including array-based comparative genomic hybridization and massively parallel genome sequencing - have considerably improved our understanding of the genetic basis of WM. Its pathogenesis, however, remains fragmented. Important steps have been made in elucidating the underlying aberrations and deregulated mechanisms of the disease, and thereby providing invaluable information for identifying biomarkers for disease diagnosis, risk stratification, and therapeutic approaches. We review the genetic basis of the disease.
- Array-based comparative genomic hybridization
- Massively parallel DNA sequencing
- Waldenström's macroglobulinemia
ASJC Scopus subject areas